Drugs News and Research

RSS

Age Intervention Eyelash products seized by U.S. Marshals

At the request of the U.S. Food and Drug Administration, U.S. Marshals seized today 12,682 applicator tubes of Age Intervention Eyelash, a product that may, in some users, lead to decreased vision.

19 Nov 2007

Rev-erb protein helps maintain the body's correct metabolism

It's well known that the body's energy levels cycle on a 24-hour, or circadian, schedule, and that this metabolic process is fueled by oxygen.

19 Nov 2007

University of Illinois at Chicago receives $2.2 million grant to develop drugs to suppress cocaine cravings

The University of Illinois at Chicago College of Pharmacy has received a $2.2 million federal grant to develop therapeutics to suppress the cravings of cocaine addicts.

19 Nov 2007

Survey reveals drug and alcohol abuse in British teens

According to a government survey in the UK almost half of all youngsters between the age of 10 and 15 say they have consumed alcohol. This survey on the lifestyles and concerns of children has revealed startling drug and alcohol abuse problems.

19 Nov 2007

Weight-loss drug doubles the risk of depression and anxiety

A weight loss pill which was initially hailed as some kind of wonder drug is now thought to more than double the risk of depression, anxiety and suicidal thoughts.

19 Nov 2007

A comprehensive survey on the health of college students

A report released by the University of Minnesota Boynton Health Service is the first of its kind in the nation to conduct a comprehensive survey on the health of college students.

16 Nov 2007

Tamiflu significantly reduces illness severity and duration in children one year and older

...particularly if given within 24 hours of symptom onset, according to new data presented at the World Society for Pediatric Infectious Disease (WISPID) meeting in Bangkok 15-18 November.

16 Nov 2007

Suppressing herpes virus may reduce infectiousness of HIV

A recent study of men co-infected with herpes simplex virus type 2 (HSV-2) and HIV revealed that drugs used to suppress HSV decrease the levels of HIV in the blood and rectal secretions, which may make patients less likely to transmit the virus.

16 Nov 2007

New understanding of how brain processes memory

Scientists at The University of Arizona have added another piece of the puzzle of how the brain processes memory.

16 Nov 2007

From successful aging to severe dementia

A recently published special issue of the Journal of Alzheimer's Disease contains the contributions from experts in the field of aging, dementia and Alzheimer's disease, who attended the "Fourth Annual Meeting on Brain aging and Dementia - From successful aging to severe dementia”, Held in Perugia in October 2006 under the auspices of the Italian Psychogeriatric Association, a member of the International Psychogeriatric Association, the meeting celebrates the centenary of Alzheimer's first description of the disease.

16 Nov 2007

How inhibitor-of-apoptosis chemicals kill tumors

Chemical compounds specially designed to neutralize proteins that would otherwise allow tumor cells to cheat death have been recognized for some time by scientists as a promising new avenue for cancer therapy.

16 Nov 2007

Prescription medication dosages often incorrect for obese patients

As if severely overweight people didn't already have enough health concerns, experts are raising another red flag - the possibility that some of their prescription medications, especially antibiotics, may not be prescribed at the appropriate dosage and could be ineffective.

16 Nov 2007

Rising drug expenditures for ADHD

The NHS is likely to face a 10-fold increase in the cost of drugs prescribed to children and adolescents with attention-deficit/hyperactivity disorder (ADHD) in the decade to 2012.

16 Nov 2007

Cethromycin achieves all endpoints in second pivotal Phase III Trial for treatment for pneumonia

Advanced Life Sciences Holdings, Inc. (Nasdaq: ADLS), today announced positive results from Trial CL-05, the second of two pivotal phase III clinical trials designed to assess the safety and effectiveness of cethromycin, a novel once-a-day oral antibiotic for the treatment of mild-to-moderate community acquired pneumonia (CAP), the sixth leading cause of death in the United States.

16 Nov 2007